“As healthcare delivery grows more complex and pushes providers to assume greater risk for total costs and quality outcomes, organizations are looking for solutions to help them make the best possible healthcare decisions,” said Stanson Health co-founder Dr. Scott Weingarten, MD, MPH. “Stanson’s combination with Premier will help us expand and scale CDS to reach more physicians, and enable providers to standardize care delivery around optimal and evidence-based healthcare processes.”

Premier will utilize existing cash on hand to fund the $51.5 million acquisition. The acquisition also provides for an additional earn-out opportunity of up to $15 million based on certain product delivery and revenue targets. The acquisition is not expected to materially impact earnings in FY2019, and is expected to be modestly accretive in future years. The transaction is expected to close in Premier's fiscal second quarter ending Dec. 31, 2018, subject to customary closing conditions.


The Stanson Health team is expected to continue to operate remotely or out of existing headquarter offices in Southern California. Dr. Weingarten will continue to lead the business unit, reporting to Leigh Anderson, President of Premier’s Performance Services segment.


About Premier Inc.
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and health systems and approximately 165,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram, and Premier’s blog for more information about the company.


About Stanson Health
Stanson Health, headquartered in Los Angeles, Calif., is a leader in developing next-generation Clinical Decision Support solutions. Stanson provides EHR-integrated, actionable real-time interventions optimized for use in the provider's clinical workflow. The clinical decision support interventions, which include the use of artificial intelligence, support health systems with initiatives to improve the quality, safety, and the value of patient care across the continuum of the health system. Stanson clinical decision support has been associated with improved clinical and financial outcomes in the peer-reviewed medical literature. Combined with relevant analytics, Stanson solutions safely guide physician decisions toward the elimination of unnecessary or inappropriate care, and help improve the quality of care. Stanson CDS solutions are currently in use in more than 300 hospitals and support approximately 100,000 healthcare providers. Stanson is the # 1 rated clinical decision support solution in the 2018 KLAS publication on Clinical Process Improvement products and is the highest rated CDS product in other available 2018 surveys evaluating available clinical decision support products.

Health IT Homepage